UBS Group’s Avanos Medical AVNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.8M | Buy |
228,431
+77,808
| +52% | +$952K | ﹤0.01% | 3543 |
|
|
2025
Q1 | $2.16M | Buy |
150,623
+35,747
| +31% | +$512K | ﹤0.01% | 3640 |
|
|
2024
Q4 | $1.83M | Buy |
114,876
+12,705
| +12% | +$202K | ﹤0.01% | 3790 |
|
|
2024
Q3 | $2.46M | Buy |
102,171
+48,402
| +90% | +$1.16M | ﹤0.01% | 2875 |
|
|
2024
Q2 | $1.07M | Sell |
53,769
-25,990
| -33% | -$518K | ﹤0.01% | 3347 |
|
|
2024
Q1 | $1.59M | Buy |
79,759
+26,979
| +51% | +$537K | ﹤0.01% | 3171 |
|
|
2023
Q4 | $1.18M | Buy |
52,780
+22,167
| +72% | +$497K | ﹤0.01% | 3307 |
|
|
2023
Q3 | $619K | Sell |
30,613
-99,282
| -76% | -$2.01M | ﹤0.01% | 3461 |
|
|
2023
Q2 | $3.32M | Buy |
129,895
+66,333
| +104% | +$1.7M | ﹤0.01% | 2247 |
|
|
2023
Q1 | $1.89M | Buy |
63,562
+40,560
| +176% | +$1.21M | ﹤0.01% | 2648 |
|
|
2022
Q4 | $622K | Sell |
23,002
-96
| -0.4% | -$2.6K | ﹤0.01% | 3525 |
|
|
2022
Q3 | $503K | Buy |
23,098
+15,234
| +194% | +$332K | ﹤0.01% | 3367 |
|
|
2022
Q2 | $215K | Sell |
7,864
-17,913
| -69% | -$490K | ﹤0.01% | 3880 |
|
|
2022
Q1 | $863K | Buy |
25,777
+14,185
| +122% | +$475K | ﹤0.01% | 3366 |
|
|
2021
Q4 | $402K | Buy |
11,592
+1,806
| +18% | +$62.6K | ﹤0.01% | 4145 |
|
|
2021
Q3 | $305K | Sell |
9,786
-1,187
| -11% | -$37K | ﹤0.01% | 4010 |
|
|
2021
Q2 | $399K | Sell |
10,973
-15,641
| -59% | -$569K | ﹤0.01% | 3900 |
|
|
2021
Q1 | $1.16M | Buy |
26,614
+16,420
| +161% | +$718K | ﹤0.01% | 3224 |
|
|
2020
Q4 | $468K | Sell |
10,194
-1,269
| -11% | -$58.3K | ﹤0.01% | 3727 |
|
|
2020
Q3 | $381K | Buy |
11,463
+142
| +1% | +$4.72K | ﹤0.01% | 3593 |
|
|
2020
Q2 | $333K | Sell |
11,321
-533
| -4% | -$15.7K | ﹤0.01% | 3664 |
|
|
2020
Q1 | $319K | Buy |
11,854
+994
| +9% | +$26.7K | ﹤0.01% | 3550 |
|
|
2019
Q4 | $366K | Sell |
10,860
-1,342
| -11% | -$45.2K | ﹤0.01% | 4149 |
|
|
2019
Q3 | $457K | Sell |
12,202
-14,780
| -55% | -$554K | ﹤0.01% | 3798 |
|
|
2019
Q2 | $1.18M | Sell |
26,982
-28,917
| -52% | -$1.26M | ﹤0.01% | 2930 |
|
|
2019
Q1 | $2.39M | Buy |
55,899
+26,173
| +88% | +$1.12M | ﹤0.01% | 2300 |
|
|
2018
Q4 | $1.33M | Sell |
29,726
-60,003
| -67% | -$2.69M | ﹤0.01% | 2767 |
|
|
2018
Q3 | $6.15M | Buy |
89,729
+27,802
| +45% | +$1.9M | ﹤0.01% | 1733 |
|
|
2018
Q2 | $3.55M | Sell |
61,927
-37,066
| -37% | -$2.12M | ﹤0.01% | 2110 |
|
|
2018
Q1 | $4.56M | Buy |
98,993
+39,728
| +67% | +$1.83M | ﹤0.01% | 1922 |
|
|
2017
Q4 | $2.74M | Sell |
59,265
-12,253
| -17% | -$566K | ﹤0.01% | 2291 |
|
|
2017
Q3 | $3.22M | Sell |
71,518
-35,609
| -33% | -$1.6M | ﹤0.01% | 2093 |
|
|
2017
Q2 | $4.21M | Buy |
107,127
+9,542
| +10% | +$375K | ﹤0.01% | 1819 |
|
|
2017
Q1 | $3.72M | Buy |
97,585
+23,819
| +32% | +$907K | ﹤0.01% | 1849 |
|
|
2016
Q4 | $2.73M | Buy |
73,766
+10,393
| +16% | +$384K | ﹤0.01% | 2037 |
|
|
2016
Q3 | $2.2M | Sell |
63,373
-30,966
| -33% | -$1.07M | ﹤0.01% | 2152 |
|
|
2016
Q2 | $3.07M | Sell |
94,339
-9,517
| -9% | -$309K | ﹤0.01% | 1883 |
|
|
2016
Q1 | $2.98M | Sell |
103,856
-24,521
| -19% | -$704K | ﹤0.01% | 1846 |
|
|
2015
Q4 | $4.29M | Sell |
128,377
-82,640
| -39% | -$2.76M | ﹤0.01% | 1629 |
|
|
2015
Q3 | $6M | Sell |
211,017
-31,730
| -13% | -$902K | ﹤0.01% | 1351 |
|
|
2015
Q2 | $9.83M | Buy |
242,747
+41,714
| +21% | +$1.69M | 0.01% | 1160 |
|
|
2015
Q1 | $9.89M | Sell |
201,033
-23,388
| -10% | -$1.15M | 0.01% | 1175 |
|
|
2014
Q4 | $10.2M | Buy |
+224,421
| New | +$10.2M | 0.01% | 1135 |
|